TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2008: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. AU - Zhang, S. AU - Zeng, H. AU - Bray, F. AU - Jemal, A. AU - Yu, X. Q. AU - He, J. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Pintova, S. AU - Dharmupari, S. AU - Moshier, E. AU - Zubizarreta, N. AU - Ang, C. AU - Holcombe, R. F. PY - 2019 DA - 2019// TI - Genistein combined with FOLFOX or FOLFOX-Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study JO - Cancer Chemotherapy Pharmacol VL - 84 UR - https://doi.org/10.1007/s00280-019-03886-3 DO - 10.1007/s00280-019-03886-3 ID - Pintova2019 ER - TY - JOUR AU - Borner, M. AU - Mingrone, W. AU - Koeberle, D. AU - Moos, R. AU - Rauch, D. AU - Saletti, P. AU - Herrmann, R. AU - Dietrich, D. AU - Lanz, D. AU - Roth, A. PY - 2006 DA - 2006// TI - The impact of cetuximab on the capecitabine plus oxaliplatin (XELOX) combination in first-line treatment of metastatic colorectal cancer (MCC): A randomized phase II trial of the Swiss Group for Clinical Cancer Research (SAKK) JO - Annals Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdn058 DO - 10.1093/annonc/mdn058 ID - Borner2006 ER - TY - STD TI - Twelves C, Wong A, Nowacki MP, Abt M, Burris H, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V. Capecitabine as Adjuvant Treatment for Stage III Colon Cancer. New England J Med. 352:2696–704. ID - ref5 ER - TY - JOUR AU - Hishinuma, E. AU - Narita, Y. AU - Saito, S. AU - Maekawa, M. AU - Akai, F. AU - Nakanishi, Y. AU - Yasuda, J. AU - Nagasaki, M. AU - Yamamoto, M. AU - Yamaguchi, H. PY - 2018 DA - 2018// TI - Functional characterization of 21 allelic variants of dihydropyrimidine dehydrogenase identified in 1070 Japanese Individuals JO - Drug Metab Dispos VL - 46 UR - https://doi.org/10.1124/dmd.118.081737 DO - 10.1124/dmd.118.081737 ID - Hishinuma2018 ER - TY - JOUR AU - Hahn, R. Z. AU - Galarza, A. F. AU - Schneider, A. AU - Antunes, M. V. AU - Schwartsmann, G. AU - Linden, R. PY - 2015 DA - 2015// TI - Improved determination of uracil and dihydrouracil in plasma after a loading oral dose of uracil using high-performance liquid chromatography with photodiode array detection and porous graphitic carbon stationary phase JO - Clin Biochem VL - 48 UR - https://doi.org/10.1016/j.clinbiochem.2015.04.019 DO - 10.1016/j.clinbiochem.2015.04.019 ID - Hahn2015 ER - TY - STD TI - Etienne MC, Lagrange JL, Dassonville O, Fleming R, Thyss A, Renee N, Schneider M, Demard F, Milano G. Population study of dihydropyrimidine dehydrogenase in cancer-patients. Bull Cancer. 1995;12:2248. ID - ref8 ER - TY - JOUR AU - Katayanagi, S. AU - Katsumata, K. AU - Mori, Y. AU - Narahara, K. AU - Shigoka, M. AU - Matsudo, T. PY - 2019 DA - 2019// TI - GSTP1 as a potential predictive factor for adverse events associated with platinum-based antitumor agent-induced peripheral neuropathy JO - Oncology Letters VL - 17 ID - Katayanagi2019 ER - TY - STD TI - Wiese MD, Sorich MJ, Kichenadasse G, Ridha Z. Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis. Pharmacogenomics. 2016;17(15):1725–32. ID - ref10 ER - TY - JOUR AU - Pan, S. AU - Yang, X. AU - Yang, L. AU - Wei, Q. AU - Yang, Y. AU - Xu, G. PY - 2011 DA - 2011// TI - Human GSTs polymorphisms in the Hakka population of south China and their associations with family history of several chronic diseases JO - Biomed Environmental Sci VL - 24 ID - Pan2011 ER - TY - STD TI - Program CTE: Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 2003. https://ctepcancergov/reporting/ctcnewhtml. Accessed 3 May 2019. UR - https://www.ctepcancergov/reporting/ctcnewhtml ID - ref12 ER - TY - JOUR AU - Falzacappa, M. V. AU - Ronchini, C. AU - Faretta, M. AU - Iacobucci, I. AU - Rorà, A. G. AU - Martinelli, G. AU - Meyer, L. H. AU - Debatin, K. M. AU - Orecchioni, S. AU - Bertolini, F. AU - Pelicci, P. G. PY - 2015 DA - 2015// TI - The combination of the PARP inhibitor rucaparib and 5FU is an effective strategy for treating acute leukemias JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0276 DO - 10.1158/1535-7163.MCT-14-0276 ID - Falzacappa2015 ER - TY - JOUR AU - Țigu, A. B. AU - Toma, V. A. AU - Moț, A. C. AU - Jurj, A. AU - Moldovan, C. S. AU - Fischer-Fodor, E. AU - Berindan-Neagoe, I. AU - Pârvu, M. PY - 2020 DA - 2020// TI - The synergistic antitumor effect of 5-fluorouracil combined with allicin against lung and colorectal carcinoma cells JO - Molecules VL - 25 UR - https://doi.org/10.3390/molecules25081947 DO - 10.3390/molecules25081947 ID - Țigu2020 ER - TY - JOUR AU - Claessens, A. K. M. AU - Ibragimova, K. I. E. AU - Geurts, S. M. E. AU - Bos, M. AU - Erdkamp, F. L. G. AU - Tjan-Heijnen, V. C. G. PY - 2020 DA - 2020// TI - The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice JO - Crit Rev Oncol Hematol VL - 153 UR - https://doi.org/10.1016/j.critrevonc.2020.102988 DO - 10.1016/j.critrevonc.2020.102988 ID - Claessens2020 ER - TY - JOUR AU - Li, M. AU - Chen, H. AU - He, J. AU - Xie, J. AU - Xia, J. AU - Liu, H. AU - Shi, Y. AU - Guo, Z. AU - Yan, H. PY - 2020 DA - 2020// TI - A qualitative classification signature for post-surgery 5-fluorouracil-based adjuvant chemoradiotherapy in gastric cancer JO - Radiother Oncol VL - S0167-8140 ID - Li2020 ER - TY - STD TI - Koopman M, Antonini NF, Douma J, Wals J, Honkoop AH, Erdkamp FL, Jong RSd, Rodenburg CJ, Vreugdenhil G, Loosveld OJ: Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet, 370:0-142. ID - ref17 ER - TY - STD TI - Tuchman M. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. N Engl J Med. 1985;313. ID - ref18 ER - TY - JOUR AU - Amstutz, U. AU - Froehlich, T. K. AU - Largiadèr, C. R. PY - 2011 DA - 2011// TI - Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity JO - Pharmacogenomics VL - 12 UR - https://doi.org/10.2217/pgs.11.72 DO - 10.2217/pgs.11.72 ID - Amstutz2011 ER - TY - JOUR AU - Lunenburg, C. A. T. C. AU - Henricks, L. M. AU - Guchelaar, H. J. AU - Swen, J. J. AU - Deenen, M. J. AU - Schellens, J. H. M. PY - 2016 DA - 2016// TI - Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time JO - Eur J Cancer (Oxford, England : 1990) VL - 54 UR - https://doi.org/10.1016/j.ejca.2015.11.008 DO - 10.1016/j.ejca.2015.11.008 ID - Lunenburg2016 ER - TY - JOUR AU - Ridge, S. A. AU - Sludden, J. AU - Brown, O. AU - Robertson, L. AU - Wei, X. AU - Sapone, A. PY - 1998 DA - 1998// TI - Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects JO - British J Clin Pharmacol VL - 46 UR - https://doi.org/10.1046/j.1365-2125.1998.00751.x DO - 10.1046/j.1365-2125.1998.00751.x ID - Ridge1998 ER - TY - JOUR AU - Mcleod, H. L. AU - Collie-Duguid, E. S. R. AU - Vreken, P. AU - Johnson, M. R. AU - Wei, X. AU - Sapone, A. AU - Diasio, R. B. AU - Fernandez-Salguero, P. AU - Kuilenberg, A. B. P. AU - Gennip, A. H. PY - 1998 DA - 1998// TI - Nomenclature for human DPYD alleles JO - Pharmacogenetics VL - 8 UR - https://doi.org/10.1097/00008571-199812000-00001 DO - 10.1097/00008571-199812000-00001 ID - Mcleod1998 ER - TY - JOUR AU - Kubota, T. PY - 2003 DA - 2003// TI - 5-Fluorouracil and dihydropyrimidine dehydrogenase JO - Int J Clin Oncol VL - 8 UR - https://doi.org/10.1007/s10147-003-0319-7 DO - 10.1007/s10147-003-0319-7 ID - Kubota2003 ER - TY - JOUR AU - Khushman, M. D. AU - Patel, G. K. AU - Hosein, P. J. AU - Laurini, J. A. AU - Cameron, D. AU - Clarkson, D. R. AU - Butler, T. W. AU - Norden, C. W. AU - Baliem, W. AU - Jones, V. PY - 2018 DA - 2018// TI - Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines JO - J Gastrointestinal Oncol VL - 9 UR - https://doi.org/10.21037/jgo.2018.02.03 DO - 10.21037/jgo.2018.02.03 ID - Khushman2018 ER - TY - JOUR AU - Joerger, M. AU - Huitema, A. D. R. AU - Boot, H. AU - Cats, A. AU - Doodeman, V. D. AU - Smits, P. H. M. AU - Vainchtein, L. AU - Rosing, H. AU - Meijerman, I. AU - Zueger, M. PY - 2015 DA - 2015// TI - Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy JO - Cancer Chemotherapy Pharmacol VL - 75 UR - https://doi.org/10.1007/s00280-015-2698-7 DO - 10.1007/s00280-015-2698-7 ID - Joerger2015 ER - TY - JOUR AU - Deenen, M. J. AU - Tol, J. AU - Burylo, A. M. AU - Doodeman, V. D. AU - Boer, A. AU - Vincent, A. AU - Guchelaar, H. J. AU - Smits, P. H. M. AU - Beijnen, J. H. AU - Punt, C. J. A. PY - 2011 DA - 2011// TI - Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer JO - Clin Cancer Res Official J Am Assoc Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2209 DO - 10.1158/1078-0432.CCR-10-2209 ID - Deenen2011 ER - TY - JOUR AU - Amirfallah, A. AU - Kocal, G. C. AU - Unal, O. U. AU - Ellidokuz, H. PY - 2018 DA - 2018// TI - DPYD, TYMS and MTHFR genes polymorphism frequencies in a series of Turkish colorectal cancer patients JO - J Pers Med VL - 8 UR - https://doi.org/10.3390/jpm8040045 DO - 10.3390/jpm8040045 ID - Amirfallah2018 ER - TY - JOUR AU - Mcleod, H. L. AU - Sargent, D. J. AU - Marsh, S. AU - Green, E. M. AU - Goldberg, R. M. PY - 2010 DA - 2010// TI - Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741 JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.21.7943 DO - 10.1200/JCO.2009.21.7943 ID - Mcleod2010 ER - TY - JOUR AU - Hayes, J. D. AU - Strange, R. C. PY - 2000 DA - 2000// TI - Glutathione S-transferase polymorphisms and their biological consequences JO - Pharmacology VL - 61 UR - https://doi.org/10.1159/000028396 DO - 10.1159/000028396 ID - Hayes2000 ER - TY - JOUR AU - Huang, G. Z. AU - Shan, W. AU - Zeng, L. AU - Huang, L. G. PY - 2013 DA - 2013// TI - The GSTP1 A1578G polymorphism and the risk of childhood acute lymphoblastic leukemia: results from an updated meta-analysis JO - Genetics Molecular Res VL - 12 UR - https://doi.org/10.4238/2013.July.24.3 DO - 10.4238/2013.July.24.3 ID - Huang2013 ER - TY - JOUR AU - Santric, V. AU - Djokic, M. AU - Suvakov, S. AU - Pljesa-Ercegovac, M. AU - Nikitovic, M. AU - Radic, T. PY - 2020 DA - 2020// TI - GSTP1 rs1138272 polymorphism affects prostate cancer risk JO - Medicina (Kaunas, Lithuania) VL - 56 UR - https://doi.org/10.3390/medicina56030128 DO - 10.3390/medicina56030128 ID - Santric2020 ER - TY - JOUR AU - Kudhair, B. K. AU - Alabid, N. N. AU - Asghar, T. -. K. AU - Lafta, I. J. PY - 2020 DA - 2020// TI - Correlation of GSTP1 gene variants of male Iraqi waterpipe (Hookah) tobacco smokers and the risk of lung cancer JO - Molecular Biology Reports VL - 47 UR - https://doi.org/10.1007/s11033-020-05359-w DO - 10.1007/s11033-020-05359-w ID - Kudhair2020 ER - TY - JOUR AU - Sophonnithiprasert, T. AU - Saelee, P. AU - Pongtheerat, T. PY - 2020 DA - 2020// TI - Glutathione S-transferase P1 polymorphism on Exon 6 and risk of hepatocellular carcinoma in Thai male patients JO - Oncology VL - 98 UR - https://doi.org/10.1159/000505213 DO - 10.1159/000505213 ID - Sophonnithiprasert2020 ER - TY - JOUR AU - Terrazzino, S. AU - Mattina, P. AU - Masini, L. AU - Caltavuturo, T. AU - Gambaro, G. AU - Canonico, P. L. AU - Genazzani, A. A. AU - Krengli, M. PY - 2012 DA - 2012// TI - Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery JO - Radiother Oncol VL - 103 UR - https://doi.org/10.1016/j.radonc.2011.12.002 DO - 10.1016/j.radonc.2011.12.002 ID - Terrazzino2012 ER - TY - JOUR AU - Osti, M. F. AU - Nicosia, L. AU - Agolli, L. AU - Gentile, G. AU - Falco, T. AU - Bracci, S. AU - Nardo, F. AU - Minniti, G. AU - Sanctis, V. AU - Valeriani, M. PY - 2017 DA - 2017// TI - Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy JO - Am J Clin Oncol VL - 40 UR - https://doi.org/10.1097/COC.0000000000000182 DO - 10.1097/COC.0000000000000182 ID - Osti2017 ER - TY - JOUR AU - Mir, O. AU - Alexandre, J. AU - Tran, A. AU - Durand, J. P. AU - Goldwasser, F. PY - 2009 DA - 2009// TI - Relationship between GSTP1 Ile 105Val polymorphism and docetaxel-induced peripheral neuropathy: Clinical evidence of a role of oxidative stress in taxane toxicity JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn698 DO - 10.1093/annonc/mdn698 ID - Mir2009 ER - TY - JOUR AU - Watson, M. A. AU - Stewart, R. K. AU - Smith, G. B. AU - Massey, T. E. AU - Bell, D. A. PY - 1998 DA - 1998// TI - Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution JO - Carcinogenesis VL - 2 UR - https://doi.org/10.1093/carcin/19.2.275 DO - 10.1093/carcin/19.2.275 ID - Watson1998 ER - TY - JOUR AU - Sweeney, C. AU - Mcclure, G. Y. AU - Fares, M. Y. AU - Stone, A. AU - Ambrosone, C. B. PY - 2000 DA - 2000// TI - Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism1 JO - Cancer Research VL - 60 ID - Sweeney2000 ER - TY - JOUR AU - Carron, J. AU - Lopes-Aguiar, L. AU - Costa, E. F. D. AU - Nogueira, G. A. S. AU - Lima, T. R. P. AU - Pincinato, E. C. AU - Visacri, M. B. AU - Quintanilha, J. C. F. AU - Moriel, P. AU - Lourenço, G. J. AU - Lima, C. S. P. PY - 2017 DA - 2017// TI - GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and severity of vomiting in head and neck cancer patients treated with cisplatin chemoradiation JO - Basic Clin Pharmacol Toxicol VL - 121 UR - https://doi.org/10.1111/bcpt.12842 DO - 10.1111/bcpt.12842 ID - Carron2017 ER -